Loading company…
Riskpilot
← Back to search
Sign in
Get full access
LAB Diagnostics Nordic AB
AB
Dissolved
Org 5568416464
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2011
4 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2019
SEK 10,6M
+67% vs 2018
EBITDA margin
-2.9%
+16% vs 2018
Equity ratio
20.6%
Financial strength
Net profit 2019
SEK 14K
+193% vs 2018
EBITDA — year on year
SEK millions
0M
0M
1M
1M
1M
0M
2016
0M
0%
2017
0M
0%
2018
0M
0%
2019
Key figures
Annual report 2019
Revenue
SEK 10,6M
+67%
EBITDA
SEK -302K
+16%
Net profit
SEK 14K
+193%
Total assets
SEK 2,7M
+7%
Equity
SEK 563K
+3%
Employees
4
—
Company information
Legal name
LAB Diagnostics Nordic AB
Org number
5568416464
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10 februari 2011
Share capital
SEK 0
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Company purpose
Försäljning av produkter och instrument samt konsultverksamhet inom biomedicin och biobank.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in
All Sweden companies
Revenue
SEK millions
0M
3M
6M
9M
13M
4M
2016
6M
2017
6M
2018
11M
2019
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
0M
2019
Income statement
SEK thousands
Item
2016
2017
2018
2019
Revenue
4 002
5 917
6 332
10 574
Staff expenses
—
—
—
—
EBITDA
91
177
−360
−302
Depreciation & amort.
−2
−1
−5
−17
EBIT
89
176
−365
−319
Net financials
−1
−2
−1
−9
Profit before tax
89
125
−15
22
Tax
−20
−33
−0
−8
Net profit
69
92
−15
14
Balance sheet
SEK thousands
Item
2016
2017
2018
2019
Total assets
3 062
1 872
2 546
2 732
Equity
473
565
549
563
Long-term debt
0
0
0
0
Short-term debt
2 589
1 257
1 997
2 169
Total debt
2 589
1 257
1 997
2 169
Financial ratios
5-year trend
EBITDA margin
-2.9%
This company
15.8%
Market median
-118% vs market
2016
2019
Equity ratio
20.6%
This company
38.2%
Market median
-46% vs market
2016
2019
Return on equity
2.5%
This company
18.4%
Market median
-86% vs market
2016
2019
Net profit margin
0.1%
This company
8.1%
Market median
-99% vs market
2016
2019
Asset turnover
3.87×
This company
1.12×
Market median
+246% vs market
2016
2019
Debt / equity
3.85×
This company
0.62×
Market median
-521% vs market
2016
2019
Annual reports & filings
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
BG
Beatrice Gida Karin Orback
Chief Executive Officer
Chief Executive Officer
2020
—
—
MC
Malin Christina Evesäter
Audit
Audit
2020
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
CI
Claes Ingemar Karlsson
Board of Directors
2020
—
—
AC
Annika Christine Sörlin Garnås
Deputy Board Member
2020
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of LAB Diagnostics Nordic AB also hold positions in
0
other companies.
Person
Role here
Other companies
Beatrice Gida Karin Orback
Chief Executive Officer
0 companies
Malin Christina Evesäter
Audit
0 companies
Claes Ingemar Karlsson
Board of Directors
0 companies
Annika Christine Sörlin Garnås
Deputy Board Member
0 companies